Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.764
-0.030 (-3.79%)
At close: Feb 21, 2025, 4:00 PM
0.770
+0.006 (0.80%)
After-hours: Feb 21, 2025, 5:07 PM EST
Jin Medical International Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2018 |
| Revenue | 23.5 | 19.82 | 19.19 | 20.76 | 16.19 | Upgrade
|
| Revenue Growth (YoY) | 18.57% | 3.29% | -7.58% | 28.22% | -20.49% | Upgrade
|
| Cost of Revenue | 13.89 | 12.86 | 12.83 | 14.18 | 10.7 | Upgrade
|
| Gross Profit | 9.61 | 6.96 | 6.36 | 6.59 | 5.5 | Upgrade
|
| Selling, General & Admin | 4.37 | 2.37 | 2.18 | 2.16 | 1.88 | Upgrade
|
| Research & Development | 1.5 | 1.54 | 1.89 | 1.57 | 1.26 | Upgrade
|
| Other Operating Expenses | 0.11 | 0.18 | 0.16 | 0.23 | - | Upgrade
|
| Operating Expenses | 5.97 | 4.1 | 4.23 | 3.95 | 3.14 | Upgrade
|
| Operating Income | 3.64 | 2.87 | 2.13 | 2.63 | 2.35 | Upgrade
|
| Interest Expense | - | - | - | -0.01 | -0.11 | Upgrade
|
| Interest & Investment Income | 0.47 | 0.18 | 0.18 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.05 | 0.19 | 0.06 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | 0.22 | 0.24 | 0.19 | 0.12 | Upgrade
|
| Pretax Income | 4.18 | 3.22 | 2.74 | 2.88 | 2.35 | Upgrade
|
| Income Tax Expense | 0.76 | 0.34 | 0.04 | 0.25 | 0.15 | Upgrade
|
| Earnings From Continuing Operations | 3.42 | 2.88 | 2.71 | 2.63 | 2.21 | Upgrade
|
| Minority Interest in Earnings | 0.26 | - | - | - | - | Upgrade
|
| Net Income | 3.68 | 2.88 | 2.71 | 2.63 | 2.21 | Upgrade
|
| Net Income to Common | 3.68 | 2.88 | 2.71 | 2.63 | 2.21 | Upgrade
|
| Net Income Growth | 27.71% | 6.34% | 2.84% | 19.30% | -39.52% | Upgrade
|
| Shares Outstanding (Basic) | 156 | 145 | 135 | 135 | 400 | Upgrade
|
| Shares Outstanding (Diluted) | 156 | 145 | 135 | 135 | 400 | Upgrade
|
| Shares Change (YoY) | 7.81% | 7.51% | - | -66.25% | - | Upgrade
|
| EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EPS Growth | 18.46% | -1.08% | 2.84% | 253.54% | -39.53% | Upgrade
|
| Free Cash Flow | -1.35 | 2.99 | 1.54 | 5.8 | 2.36 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.02 | 0.01 | 0.04 | 0.01 | Upgrade
|
| Gross Margin | 40.89% | 35.14% | 33.13% | 31.72% | 33.95% | Upgrade
|
| Operating Margin | 15.48% | 14.47% | 11.10% | 12.67% | 14.54% | Upgrade
|
| Profit Margin | 15.64% | 14.52% | 14.10% | 12.67% | 13.62% | Upgrade
|
| Free Cash Flow Margin | -5.75% | 15.10% | 8.03% | 27.93% | 14.58% | Upgrade
|
| EBITDA | 3.88 | 3.09 | 2.49 | 2.98 | 2.68 | Upgrade
|
| EBITDA Margin | 16.49% | 15.61% | 12.99% | 14.34% | 16.58% | Upgrade
|
| D&A For EBITDA | 0.24 | 0.23 | 0.36 | 0.35 | 0.33 | Upgrade
|
| EBIT | 3.64 | 2.87 | 2.13 | 2.63 | 2.35 | Upgrade
|
| EBIT Margin | 15.48% | 14.47% | 11.10% | 12.67% | 14.54% | Upgrade
|
| Effective Tax Rate | 18.26% | 10.67% | 1.32% | 8.63% | 6.25% | Upgrade
|
| Revenue as Reported | 23.5 | 19.82 | 19.19 | 20.76 | 16.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.